
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16072317
[patent_doc_number] => 20200190145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ANTIMICROBIAL PEPTIDES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/608025
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608025 | Antimicrobial peptides and their use | Apr 23, 2018 | Issued |
Array
(
[id] => 15895393
[patent_doc_number] => 20200147215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => DRUG CONJUGATES WITH PHOTOCLEAVABLE SOLUBILITY MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/607573
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607573 | DRUG CONJUGATES WITH PHOTOCLEAVABLE SOLUBILITY MODULATORS | Apr 23, 2018 | Abandoned |
Array
(
[id] => 13490191
[patent_doc_number] => 20180296638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-ss
[patent_app_type] => utility
[patent_app_number] => 15/946238
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946238
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946238 | Compositions for treating heart disease by inhibiting the action of mAKAP-b | Apr 4, 2018 | Issued |
Array
(
[id] => 15052341
[patent_doc_number] => 10456446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Use of human small leucine zipper protein in osteogenesis procedure
[patent_app_type] => utility
[patent_app_number] => 15/945858
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9344
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945858
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945858 | Use of human small leucine zipper protein in osteogenesis procedure | Apr 4, 2018 | Issued |
Array
(
[id] => 17975542
[patent_doc_number] => 11492390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Mutant alpha-1-antitrypsin compositions and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/499534
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 12423
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499534 | Mutant alpha-1-antitrypsin compositions and use thereof | Apr 1, 2018 | Issued |
Array
(
[id] => 17974394
[patent_doc_number] => 11491231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials
[patent_app_type] => utility
[patent_app_number] => 15/941626
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 24
[patent_no_of_words] => 7267
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/941626 | Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials | Mar 29, 2018 | Issued |
Array
(
[id] => 13519541
[patent_doc_number] => 20180311313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => COMPOSITION HAVING TISSUE-REPAIRING ACTIVITY, AND USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/938839
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938839 | Composition having tissue-repairing activity, and use therefor | Mar 27, 2018 | Issued |
Array
(
[id] => 13328581
[patent_doc_number] => 20180215828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => SYNTHETIC ANTIBODY MIMIC PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/937809
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/937809 | SYNTHETIC ANTIBODY MIMIC PEPTIDES | Mar 26, 2018 | Abandoned |
Array
(
[id] => 18375997
[patent_doc_number] => 20230151079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => RECOMBINANT PROTEIN AND FRAGMENTS THEREOF, METHOD FOR PRODUCING SAID RECOMBINANT PROTEIN, SYNTHETIC GENE AND USE OF SCULPTIN OR RECOMBINANT PROTEIN FOR PREPARING A MEDICAMENT OR PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF THROMBOEMBOLIC DISEASES OR AS A DIRECT AND SPECIFIC INHIBITOR OF THROMBIN
[patent_app_type] => utility
[patent_app_number] => 16/495905
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495905 | Recombinant protein and fragments thereof, method for producing said recombinant protein, synthetic gene and use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition for the prophylaxis and/or treatment of thromboembolic diseases or as a direct and specific inhibitor of thrombin | Mar 20, 2018 | Issued |
Array
(
[id] => 14069499
[patent_doc_number] => 20190083637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => TUMOR CELL-SPECIFIC RESPONSIVE SELF-ASSEMBLING DRUG NANOCONJUGATE
[patent_app_type] => utility
[patent_app_number] => 15/925830
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925830
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/925830 | Tumor cell-specific responsive self-assembling drug nanoconjugate | Mar 19, 2018 | Issued |
Array
(
[id] => 15496229
[patent_doc_number] => 20200048303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/492248
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492248 | Antimicrobial peptides and methods of making and using same | Mar 11, 2018 | Issued |
Array
(
[id] => 16053233
[patent_doc_number] => 20200188471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 16/496866
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496866 | APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | Mar 1, 2018 | Abandoned |
Array
(
[id] => 15209789
[patent_doc_number] => 20190367581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => VSIG8-BASED CHIMERIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/484854
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484854 | VSIG8-based chimeric proteins | Feb 26, 2018 | Issued |
Array
(
[id] => 15345283
[patent_doc_number] => 20200010533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Modified serpins for the treatment of bradykinin-mediated disease
[patent_app_type] => utility
[patent_app_number] => 16/487858
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487858 | Modified serpins for the treatment of bradykinin-mediated disease | Feb 22, 2018 | Issued |
Array
(
[id] => 16190793
[patent_doc_number] => 20200231642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PEPTIDE KINASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/486832
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486832 | PEPTIDE KINASE INHIBITORS AND METHODS OF USE THEREOF | Feb 18, 2018 | Abandoned |
Array
(
[id] => 19273312
[patent_doc_number] => 12023419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Prokaryotic collagen therapeutics for postoperative adhesions
[patent_app_type] => utility
[patent_app_number] => 15/898482
[patent_app_country] => US
[patent_app_date] => 2018-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 23
[patent_no_of_words] => 12393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/898482 | Prokaryotic collagen therapeutics for postoperative adhesions | Feb 16, 2018 | Issued |
Array
(
[id] => 17007098
[patent_doc_number] => 20210238259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/478747
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478747 | FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME | Jan 30, 2018 | Abandoned |
Array
(
[id] => 12769981
[patent_doc_number] => 20180148495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => VARIANT FACTOR VIII POLYPEPTIDES AND METHODS OF THEIR PRODUCTION AND USE
[patent_app_type] => utility
[patent_app_number] => 15/878012
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878012 | Variant factor VIII polypeptides and methods of their production and use | Jan 22, 2018 | Issued |
Array
(
[id] => 12746527
[patent_doc_number] => 20180140676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => RAPID-ACTING INSULIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/868272
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/868272 | Rapid-acting insulin compositions | Jan 10, 2018 | Issued |
Array
(
[id] => 15178119
[patent_doc_number] => 20190359651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => CENTRAL NERVOUS SYSTEM HOMING PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/477125
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477125 | Central nervous system homing peptides and uses thereof | Jan 9, 2018 | Issued |